Sector: Pharmaceuticals & Biotechnology
|Small Cap
Brooks Laboratories Ltd.
₹56.41
₹54.54
₹56.41
₹36.30
₹164.02
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 16.57 | 23.45 | 25.51 | 23.32 | 38.45 |
| Operating Expense | 15.83 | 20.93 | 22.38 | 21.74 | 36.59 |
| Operating Profit | 0.73 | 2.52 | 3.13 | 1.58 | 1.86 |
| Depreciation | 0.39 | 0.39 | 0.39 | 0.39 | 0.78 |
| Interest | 0.16 | 0.28 | 0.30 | 0.26 | 0.45 |
| Tax | 0 | 0 | 0 | 0.18 | 0 |
| Net Profit | 0.30 | 2.24 | 2.65 | 1.37 | 0.72 |
₹56.41
↗ Bullish Moving Average
8
↘ Bearish Moving Average
8
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 59.1 | 52.6 | 52.6 | 52.6 | 52.6 | 52.6 |
| FII | 0 | 0 | 0 | 0 | 0.1 | 0.2 |
| DII | 3.9 | 10.4 | 10.4 | 10.4 | 10.4 | 10.4 |
| Public | 37.1 | 37 | 37 | 37 | 36.9 | 36.8 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 64.32 K | 64.32 K | 100.00% |
| Week | 61.98 K | 61.98 K | 100.00% |
| 1 Month | 1.14 L | 1.14 L | 100.00% |
| 6 Month | 64.42 K | 1.17 L | 54.95% |
MACD Crossover Above Signal Line
Positive Breakout Second Resistance ( LTP > R2)
Price crossing above SMA20 today, and greater than SMA5
Buy Zone: Stocks in the buy zone based on days traded at current PE and P/BV
Undervalued Growth Stocks
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Effectively using its capital to generate profit - RoCE improving in last 2 years
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
MACD crossed above signal line previous end of day
Top Gainers
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| No Record Found | ||||
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹492.90 | ₹6.40 | ₹131.01 | ₹13.79 | ₹559.75 | ₹852.80 |
| % Change | 1.27% | -2.14% | 0.71% | -0.86% | 0.46% | 0.53% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | - | ₹502.55 | ₹1,630.02 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | - | ₹57.92 | ₹140.92 |
| PE TTM | - | -1.50 | 34.50 | - | 28.10 | 34.70 |
| 1 Year Return | 24.95 | 544 | 4.98 | 51.43 | -21.64 | -3.98 |
| ROCE | 3.56 | -5.63 | - | - | 23.87 | 15.27 |
Valiant Laboratories Ltd.
₹ 78.00
+1.46%
Sigachi Industries Ltd.
₹ 20.34
-0.05%
Windlas Biotech Ltd.
₹ 784.40
-0.70%
Vineet Laboratories Ltd.
₹ 35.00
-1.69%
Solara Active Pharma Sciences Ltd.
₹ 556.00
+1.44%
Zim Laboratories Ltd.
₹ 99.45
-0.71%
Medico Remedies Ltd.
₹ 48.93
+2.28%
Dishman Carbogen Amcis Ltd.
₹ 198.45
+1.58%
Lasa Supergenerics Ltd.
₹ 8.07
+1.00%
Advanced Enzyme Technologies Ltd.
₹ 376.50
+0.36%
Bajaj Healthcare Ltd.
₹ 302.20
-1.10%
Ortin Global Ltd.
₹ 15.06
-3.46%
RPG Life Sciences Ltd.
₹ 2243.00
-2.22%
Bafna Pharmaceuticals Ltd.
₹ 135.50
+0.35%
Alpa Laboratories Ltd.
₹ 67.85
-1.89%
SMS Pharmaceuticals Ltd.
₹ 371.45
-2.62%
Nectar Lifesciences Ltd.
₹ 12.03
-0.25%
Mangalam Drugs and Organics Ltd.
₹ 29.01
-1.36%
Indoco Remedies Ltd.
₹ 195.70
-1.70%
Ind-Swift Laboratories Ltd.
₹ 133.00
+0.92%
Lincoln Pharmaceuticals Ltd.
₹ 722.00
-1.65%
Panacea Biotec Ltd.
₹ 419.90
+0.32%
Medicamen Biotech Ltd.
₹ 268.35
-0.45%
By signing up I certify terms, conditions & privacy policy